Further investigations are warranted to delineate the precise mechanisms by which ISL modulates STAT3 signalling and the potentialnvolvement of other signalling cascades in mediating its anti‐metastatic effects in NPC cells. This evidence concerns the gene STAT3 and nasopharyngeal carcinoma.